Awards and Initiatives

About the Initiative

The objective of the Conference Support Initiative is to provide support for PC4 Early-to-Mid Career researchers (EMCR) and PhD members to attend and present their PC4-supported cancer in primary care research at national conferences within Australia.

Four awards (up to $500 ex GST) will be available through the Conference Support Initiative (2026 – Round 2).  Please note: applicant and conference eligibility apply.

Funds from the Conference Support Initiative can be used to support the following:

• Travel to and from the conference
• Accommodation
• Registration costs (excluding networking events)

The applicant may have paid for eligible activities prior to the outcome of their application being announced. Payment to successful applicants will be made once the applicant has attended their nominated conference and proof of expenditure* has been provided to the PC4 Office.

*The expenses must have been paid by the applicant (not their employer) and will only be reimbursed to the applicant. Any costs covered by their employer will not be eligible.

Key Dates 

2026-Round 2 Key Dates

Eligibility requirements

Applicant eligibility:

• Must be a PC4 member (or submitted an application)
• Must be an EMCR (defined as less than 10 research-active years since PhD awarded) or PhD student
• Must have an abstract accepted for an oral or poster session at a national research conference prior to application closing date (Tuesday 20 October 2026)
• The accepted abstract must be for a cancer in primary care research project that PC4 has supported during its development. PC4 support may include presenting the project at an Engine Room meeting, CDW/PRW or receiving CAG input. Researchers are encouraged to contact PC4 Office by emailing info@pc4tg.com.au to check eligibility if uncertain.

Conference eligibility:

• Conference must be held in Australia between Sunday 15 October 2026 – Tuesday 15 December 2026. 
• Conference must be held outside of the city of your residence.
• Priority will be given to applicants attending COSA or GP26, however other primary care and cancer national conferences will be considered (please note: the requirement for abstract acceptance prior to application closing date).

Assessment criteria

Applications will be assessed on the following:

• All applicant and conference eligibility requirements must be met
• Higher priority will be given to applicants attending COSA or GP26 and have an accepted oral presentation
• Other areas of assessment will include the applicant’s statement regarding how attendance at the conference will be beneficial for their professional development.